Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-145183
Filing Date
2024-05-22
Accepted
2024-05-22 19:27:00
Documents
2
Group Members
FULLERTON MANAGEMENT PTE LTDTEMASEK LIFE SCIENCES PRIVATE LTDV-SCIENCES INVESTMENTS PTE LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d824356dsc13ga.htm SC 13G/A 87302
2 EX-99.1 d824356dex991.htm EX-99.1 9042
  Complete submission text file 0001193125-24-145183.txt   98514
Mailing Address 60B ORCHARD ROAD #06-18 TOWER 2 THE ATRIUM@ORCHARD SINGAPORE U0 238891
Business Address 60B ORCHARD ROAD #06-18 TOWER 2 THE ATRIUM@ORCHARD SINGAPORE U0 238891 65 6828 6828
Temasek Holdings (Private) Ltd (Filed by) CIK: 0001021944 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88402 | Film No.: 24974901
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)